MedTrace Logo

N2 Lung Cancer Project: Neoadjuvant Treatment Followed Surgery Versus Chemoradiation

NCT02966769 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 294

Last updated 2018-02-19

No results posted yet for this study

Summary

The objective of this multicenter retrospective study is to compare overall survival in patients with stage IIIA-N2 NSCLC treated with neoadjuvant treatment and surgery versus definitive chemoradiation.

Secondary objectives are to analyze disease-free survival, median survival, locoregional and distant relapses as well as mortality and toxicity related to treatment.

Conditions

  • Non-small-Cell Lung Carcinoma
  • Surgery
  • Stage IIIA-N2
  • Chemoradiation
  • Survival

Interventions

OTHER

Overall survival

Compare overall survival between both groups.

Sponsors & Collaborators

  • Grupo de Investigación Clínica en Oncología Radioterapia

    lead OTHER

Principal Investigators

  • Felipe Couñago, MD PhD · Grupo de Investigación Clínica en Oncología Radioterapia

  • Sara Montemuiño, MDPhd · Grupo de Investigación Clínica en Oncología Radioterapia

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02966769 on ClinicalTrials.gov